Nektar Therapeutics :
NKTR
NKTR
Stock Data
$86.46
$1.42 (1.67%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Nektar Therapeutics is a biopharmaceutical firm based in San Francisco, focusing on creating innovative medicines in immunotherapy. The company is working on treatments for a range of conditions, including systemic lupus erythematosus, ulcerative colitis, atopic dermatitis, psoriasis, non-Hodgkin’s lymphoma, multiple myeloma, and various cancers. With a strong commitment to advancing healthcare, Nektar Therapeutics collaborates with leading pharmaceutical companies worldwide to bring new therapies to patients in need.
All Nektar Therapeutics Articles
59 Articles